| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Common Stock | 7.69 M | $146 M | $19.00 | Jun 28, 2021 | Direct |
| Korro Bio, Inc. | 10%+ Owner | Common Stock | 1.09 M | $61.1 M | $56.00 | Apr 22, 2024 | Direct |
| NeueHealth, Inc. | 10%+ Owner | Warrant (Right to Buy) | 124 K | Apr 8, 2024 | Direct | ||
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Series A-2 convertible preferred stock | 0 | Jun 28, 2021 | Direct | ||
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Series B convertible preferred stock | 0 | $2.00 | Jun 28, 2021 | Direct | |
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Series C convertible preferred Stock | 0 | Jun 28, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KRRO | Korro Bio, Inc. | Apr 22, 2024 | 1 | $1 M | 4 | Apr 24, 2024 | 10%+ Owner |
| NEUE | NeueHealth, Inc. | Apr 8, 2024 | 1 | $0 | 4 | Apr 10, 2024 | 10%+ Owner |
| FREQ | Korro Bio, Inc. | Nov 3, 2023 | 0 | $0 | 3 | Nov 7, 2023 | 10%+ Owner |
| BHG | Bright Health Group Inc. | Oct 17, 2022 | 0 | $0 | 3/A | Oct 20, 2022 | 10%+ Owner |
| GLUE | Monte Rosa Therapeutics, Inc. | Jun 28, 2021 | 7 | $20 M | 4 | Jun 30, 2021 | 10%+ Owner |
| GLUE | Monte Rosa Therapeutics, Inc. | Jun 23, 2021 | 0 | $0 | 3 | Jun 23, 2021 | 10%+ Owner |